Long-term outcome of panic disorder with agoraphobia treated by exposure
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Background. There is a paucity of long-term outcome studies of panic disorder that exceed a 2-year follow-up. The aim of the study was to evaluate the long-term follow-up of patients with panic disorder with agoraphobia treated according to a standardized protocol. Methods. A consecutive series of 200 patients satisfying the DSM-IV criteria for panic disorder with agoraphobia was treated in an out-patient clinic with behavioural methods based on exposure homework. One hundred and thirty-six patients became panic free after 12 sessions of psychotherapy and 132 were available for follow-up. A 2- to 14-year (median = 8 years) follow-up was performed. Survival analysis was employed to characterize the clinical course of patients. Results. Thirty-one of the 132 patients (23%) had a relapse of panic disorder at some time during follow-up. The estimated cumulative percentage of patients remaining in remission was 93·1 after 2 years, 82·4 after 5 years, 78·8 after 7 years and 62·1 after 10 years. Such probabilities increased with younger age, and in the absence of a personality disorder, of high pre-treatment levels of depressed mood, of residual agoraphobic avoidance after exposure, and of concurrent use of benzodiazepines and antidepressant drugs. Conclusions. The findings suggest that exposure treatment can provide lasting relief to the majority of patients with panic disorder and agoraphobia. Disappearance of residual and subclinical agoraphobic avoidance, and not simply of panic attacks, should be the aim of exposure therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“almost half of the patients with OCD failed to respond to CBT (Fava et al. 2001).”
From Comparison between obsessive compulsive disorder and panic disorder on metacognitive beliefs, emotional schemas, and cognitive flexibility (2019) · cites this paper as Fava et al. 2001
In the citing paper
“there are some patients who fail to respond to CBT or experience a relapse after initial improvement.”
From Comparison between obsessive compulsive disorder and panic disorder on metacognitive beliefs, emotional schemas, and cognitive flexibility (2019) · cites this paper as Fava et al. 2001
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Statistical Methods for Survival Data Analysis.
Lachenbruch, P. A., & Lee, E. T. (1993) · Journal of the American Statistical Association · doi:10.2307/2290742 · Cited by 2,845
Behavioral treatment of panic disorder
Barlow, D. H., Craske, M. G., Cerny, J. A., & Klosko, J. S. (1989) · Behavior Therapy · doi:10.1016/s0005-7894(89)80073-5 · Cited by 627
Marks, I. M., Swinson, R. P., Başoǧlu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P. T., Kirby, M., McNamee, G., Sengun, S., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.6.776 · Cited by 478 · cited 2×
“This finding supports four previous investigations (Marks et al. 1993; Brown & Barlow, 1995; Otto et al. 1996; Van Balkom et al. 1996), but not the study of Oei et al. (1997).”
BackgroundResultHall, J., & Jones, D. C. (1950) · The British Journal of Sociology · doi:10.2307/587306 · Cited by 437
Major Depression in Patients With Agoraphobia and Panic Disorder
Breier, A. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790230015002 · Cited by 317 · cited 2×
“Panic disorder is usually more severe and incapacitating when it coexists with depressive symptoms (Breier et al. 1984) and these latter were found to be related to chronicity in a 7-year follow-up study (Noyes et al.”
BackgroundBehavioral treatment of panic disorder: A two-year follow-up
Craske, M. G., Brown, T. A., & Barlow, D. H. (1991) · Behavior Therapy · doi:10.1016/s0005-7894(05)80367-3 · Cited by 258 · cited 1×
“The results are consistent with previous studies on cognitivebehavioural treatment of panic with follow-up up to 3±5 years (Craske et al. 1991; Evans et al. 1991; Margraf et al. 1993; Marks et al. 1993; Bakker et al. 1995; Gould et al. 1995; Milrod & Bush, 1996; Kilic: et al. 1997; Martinsen et al.…”
ResultThe clinical interview for depression
Paykel, E. S. (1985) · Journal of Affective Disorders · doi:10.1016/0165-0327(85)90014-x · Cited by 190
Part 2. Improvement criteria in drug trials with neurotic patients
Kellner, R. (1972) · Psychological Medicine · doi:10.1017/s0033291700045645 · Cited by 103
Characterological traits of recovered patients with panic disorder and agoraphobia
Saviotti, F. M., Grandi, S., Savron, G., Ermentini, R., Bartolucci, G., Conti, S., & Fava, G. A. (1991) · Journal of Affective Disorders · doi:10.1016/0165-0327(91)90023-l · Cited by 82 · cited 1×
“Co-morbidity was assessed at the end of treatment, to minimize state-trait contaminations (Saviotti et al. 1991; Rafanelli et al. 2000), using again the Schedule for Affective Disorders and Schizophrenia (Endicott & Spitzer, 1978).”
MethodSelf-citation
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“two years and 62% after 10 years [194].”
BackgroundScreening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D)“
Gräfe, K., Zipfel, S., Herzog, W., & Löwe, B. (2004) · Diagnostica · doi:10.1026/0012-1924.50.4.171 · Cited by 801
Fear Extinction and Relapse: State of the Art
Vervliet, B., Craske, M. G., & Hermans, D. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185542 · Cited by 671
“For example 23% to 27% of patients with panic disorder reportedly relapse (Brown & Barlow 1995, Fava et al. 2001) following exposure-based therapies.”
BackgroundSix-Year Outcome of Cognitive Behavior Therapy for Prevention of Recurrent Depression
Fava, G. A., Ruini, C., Rafanelli, C., Finos, L., Conti, S., & Grandi, S. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1872 · Cited by 392
“The second line of evidence is based on the fact that in anxiety disorders, treatment of phobic disturbances was found to entail beneficial effects on the incidence of depression during long-term follow-up (20, 21).”
BackgroundSelf-citationvan Dis, E. A. M., van Veen, S. C., Hagenaars, M. A., Batelaan, N. M., Bockting, C. L. H., van den Heuvel, R. M., Cuijpers, P., & Engelhard, I. M. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3986 · Cited by 335
Andrews, G., Bell, C., Boyce, P., Gale, C., Lampe, L., Marwat, O., Rapee, R., & Wilkins, G. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418799453 · Cited by 243
Detecting panic disorder in medical and psychosomatic outpatients
Löwe, B., Gräfe, K., Zipfel, S., Spitzer, R. L., Herrmann-Lingen, C., Witte, S., & Herzog, W. (2003) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00072-2 · Cited by 252
“Despite its association with high levels of personal suffering, increased disability, and good response to treatment [7–11], it is likely that less than 10% of panic disorder cases are detected by primary care physicians [1].”
BackgroundStaging of Mental Disorders: Systematic Review
Cosci, F., & Fava, G. A. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000342243 · Cited by 235
Self-citationCan long-term treatment with antidepressant drugs worsen the course of depression?
Fava, G. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0204 · Cited by 223
Self-citationCombined psychotherapy plus antidepressants for panic disorder with or without agoraphobia
Furukawa, T. A., Watanabe, N., & Churchill, R. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004364.pub2 · Cited by 195
Greeven, A., van Balkom, A. J. L. M., Visser, S., Merkelbach, J. W., van Rood, Y. R., van Dyck, R., Van der Does, A. J. W., Zitman, F. G., & Spinhoven, P. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.1.91 · Cited by 183
Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: Systematic review
Furukawa, T. A., Watanabe, N., & Churchill, R. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.4.305 · Cited by 163
“…relapse rates not only when discontinued (Mavissakalian & Perel, 2002), but even when maintained at adequate dosage (Simon et al, 2002), whereas psychotherapy is associated with fewer relapses in the short term, but may not always be able to prevent them in the long term (Fava et al, 2001).”
BackgroundThe mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158
“…antidepressant drugs and increased relapse risk of panic disorder has been reported by other investigators (Brown andBarlow, 1995;Otto et al., 1996; Fava et al., 2001) anddepressionwas found to occur also during the follow-up of patients receiving tricyclic antidepressants for panic disorder…”
Self-citationAgoraphobia: a review of the diagnostic classificatory position and criteria
Wittchen, H.-U., Gloster, A. T., Beesdo-Baum, K., Fava, G. A., & Craske, M. G. (2010) · Depression and Anxiety · doi:10.1002/da.20646 · Cited by 150
“In the longest follow-up study of PD with AG treated by exposure (2–14 years), the presence of residual AG was a strong predictor of relapse into panic.([174]) Additional factors that significantly contribute to chronicity and relapse are comorbid depression, personality disorders, and high scores on dispositional mea…”
BackgroundSelf-citationRecurrence of anxiety disorders and its predictors
Scholten, W. D., Batelaan, N. M., van Balkom, A. J., WJH. Penninx, B., Smit, J. H., & van Oppen, P. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.031 · Cited by 146
Residual symptoms in depression
Fava, G. A., Fabbri, S., & Sonino, N. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00226-9 · Cited by 137
Self-citationBullis, J. R., Fortune, M. R., Farchione, T. J., & Barlow, D. H. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.07.016 · Cited by 130
“When the maintenance of remission status following a course of CBT is assessed beyond a 2-year follow-up, studies suggest that approximately 1 out of 4 patients with an anxiety disorder will experience a reoccurrence of symptoms [6–8].”
BackgroundFang, S., Chen, C., Chang, I., Wu, E. C., Chang, C., & Lin, K. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.017 · Cited by 134
Guidi, J., Fava, G. A., Fava, M., & Papakostas, G. I. (2011) · Psychological Medicine · doi:10.1017/s0033291710000826 · Cited by 118
“Moreover, various studies have demonstrated that exposure-based behavioral therapy may yield longterm benefits to the majority of patients suffering from panic disorder with agoraphobia (Fava et al. 2001b), social phobia (Fava et al.”
BackgroundSelf-citationPanic Disorder and Migraine: Comorbidity, Mechanisms, and Clinical Implications
Smitherman, T. A., Kolivas, E. D., & Bailey, J. R. (2013) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12004 · Cited by 105
“Long-term follow-up data indicate that up to approximately 80% of patients treated with PCT techniques remain in remission after 5 years.(150) For patients at risk for relapse or anxiety-related withdrawal symptoms following benzodiazepine withdrawal, PCT is also highly efficacious for facilitating long-term benzodiaz…”
BackgroundHeldt, E., Manfro, G. G., Kipper, L., Blaya, C., Maltz, S., Isolan, L., Hirakata, V. N., & Otto, M. W. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000067188 · Cited by 87
“and treatment of such symptoms may aid relapse prevention [”
BackgroundRoberge, P., Marchand, A., Reinharz, D., & Savard, P. (2008) · Behavior Modification · doi:10.1177/0145445507309025 · Cited by 84
“Although both treatments offer similar short-term outcomes, CBT appears to offer superior maintenance of gains over time, whereas discontinuation of medication is associated with high relapse rates (Fava et al., 2001; Gould, Otto, & Pollack, 1995; White & Barlow, 2001).”
BackgroundLong-term outcome of social phobia treated by exposure
FAVA, G. A., GRANDI, S., RAFANELLI, C., RUINI, C., CONTI, S., & BELLUARDO, P. (2001) · Psychological Medicine · doi:10.1017/s0033291701004020 · Cited by 84
“This finding supports previous investigations on panic disorder with agoraphobia (Marks et al. 1993; Brown & Barlow, 1995; Otto et al. 1996; Van Balkom et al. 1996; Fava et al. 2001).”
ResultInfluentialSelf-citationFava, G. A., Bernardi, M., Tomba, E., & Rafanelli, C. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007462 · Cited by 80
“The two scales consist of specific anchor points and were found to yield a sensitive measurement of change upon behavioural treatment in panic disorder (Fava et al., 1994, 2001).”
BackgroundMethodSelf-citationThe Clinical Interview for Depression: A Comprehensive Review of Studies and Clinimetric Properties
Guidi, J., Fava, G. A., Bech, P., & Paykel, E. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000317532 · Cited by 79
“Regular assessments of panic attacks, agoraphobic avoidance, and depressed mood used the CID. For those patients who did not relapse, the level of agoraphobia tended to decrease gradually over time whereas patients who relapsed showed an increase in agoraphobic avoidance before relapse, indicating that in a substantia…”
MethodSelf-citationDiscontinuing Antidepressant Drugs: Lesson from a Failed Trial and Extensive Clinical Experience
Fava, G. A., & Belaise, C. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000492693 · Cited by 77
Self-citationHajós‐Korcsok, É., Robinson, D. D., Yu, J. H., Fitch, C., Walker, E. L., & Merchant, K. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)01047-x · Cited by 87
Meyerbroeker, K., Morina, N., Kerkhof, G. A., & Emmelkamp, P. M. G. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000342715 · Cited by 70
Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs
Fava, G. A., & Cosci, F. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19com12794 · Cited by 69
Self-citationEvidence-based pharmacotherapy of panic disorder: an update
Batelaan, N. M., Van Balkom, A. J. L. M., & Stein, D. J. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000800 · Cited by 67
“Third, providing psychotherapy to panic disorder patients may also be beneficial in enhancing the longterm outcome for several reasons, the most important reason being that the effects of CBT may be maintained over time (Bakker et al. 1998; Fava et al. 2001; Oei et al. 1999; Peter et al. 2008).”
BackgroundCombined psychotherapy plus benzodiazepines for panic disorder
Watanabe, N., Churchill, R., & Furukawa, T. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005335.pub2 · Cited by 65
Long-Term Treatment with Antidepressant Drugs: The Spectacular Achievements of Propaganda
Fava, G. A. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000056279 · Cited by 66
Self-citationWhen Anxiety and Depression Coexist: The Role of Differential Diagnosis Using Clinimetric Criteria
Cosci, F., & Fava, G. A. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000517518 · Cited by 63
Self-citationLorimer, B., Kellett, S., Nye, A., & Delgadillo, J. (2021) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2020.1812709 · Cited by 62
A comparative study of early maladaptive schemas in obsessive–compulsive disorder and panic disorder
Kwak, K. H., & Lee, S. J. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.11.015 · Cited by 67
“up (Fava et al., 2001).”
Belaise, C., Fava, G. A., & Marks, I. M. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000085144 · Cited by 55
“and were on no psychotropic drugs. Case Reports Case 1 While walking in the street, X, a woman aged 19 who was a virgin, was suddenly pushed into a passing car with 4 young men, taken into the countryside and raped by them all. She was left there and wandered for a couple of hours in acute shock.Three months later X s…”
BackgroundSelf-citationGloster, A. T., Hauke, C., Höfler, M., Einsle, F., Fydrich, T., Hamm, A. O., Sthröhle, A., & Wïttchen, H. (2013) · Behaviour Research and Therapy · doi:10.1016/j.brat.2013.09.009 · Cited by 65
“The observed effect sizes, response rates, and percentage of patients with reliable change were consistent with and sometimes better than previous two-year outcome studies for panic disorder with and without agoraphobia (e.g., Craske, Brown, & Barlow, 1991; Fava et al., 2001; Marchand, Roberge, Primiano, & Germain, 20…”
ResultVirtual Reality as a Tool for Cognitive Behavioral Therapy: A Review
Scozzari, S., & Gamberini, L. (2011) · Studies in computational intelligence · doi:10.1007/978-3-642-17824-5_5 · Cited by 70
“A considerable amount of evidence on the effectiveness of exposure techniques in the treatment of anxiety disorders has been gathered in the last decades [12], [13], [14], [15] [16].”
BackgroundPrognostic indices with brief and standard CBT for panic disorder: II. Moderators of outcome
DOW, M. G. T., KENARDY, J. A., JOHNSTON, D. W., NEWMAN, M. G., TAYLOR, C. B., & THOMSON, A. (2007) · Psychological Medicine · doi:10.1017/s0033291707000682 · Cited by 50
“Concomitant drug treatment at the time of remission of anxiety with cognitive behavioural therapy (CBT) has also been associated with higher rates of relapse compared to CBT alone (Marks et al. 1993; Brown & Barlow, 1995; Van Balkom et al. 1996; Otto et al. 1996; Fava et al. 2001 ), although Oei et al. (1997) failed t…”
BackgroundResultvon Brachel, R., Hirschfeld, G., Berner, A., Willutzki, U., Teismann, T., Cwik, J. C., Velten, J., Schulte, D., & Margraf, J. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000500188 · Cited by 49
Reddy, Y. C., Sudhir, P., Manjula, M., Arumugham, S., & Narayanaswamy, J. (2020) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_773_19 · Cited by 48
“[20] A long-term follow-up study of PD patients treated with CBT reported a relapse rate of 23% over 2–14 years of follow-up period.[21]”
BackgroundSkapinakis, P., Lewis, G., Davies, S., Brugha, T., Prince, M., & Singleton, N. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2010.06.004 · Cited by 48
“The presence of depression has been found in the past to worsen the course, outcome and quality of life of patients with anxiety disorders in general or panic syndromes in particular [11,42].”
BackgroundRecurrence of anxiety disorders and its predictors in the general population
Scholten, W., ten Have, M., van Geel, C., van Balkom, A. J. L. M., de Graaf, R., & Batelaan, N. M. (2021) · Psychological Medicine · doi:10.1017/s0033291721002877 · Cited by 59
“The results of this study further show that a current depressive disorder (at baseline) is a predictor of recurrence of anxiety, which is in line with results from previous studies (Bruce et al., 2005; Fava et al., 2001b; Nay et al., 2013).”
BackgroundResultMarchand, A., Roberge, P., Primiano, S., & Germain, V. (2009) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2009.07.019 · Cited by 63
“Cognitive-behavioral treatments have been shown to offer high effect sizes, superior maintenance of gains over time, and lower rates of relapse compared to pharmacological treatment (Fava et al., 2001; Foldes-Busque et al., 2007; Gould, Otto, & Pollack, 1995; White & Barlow, 2001).”
BackgroundResultEvidence-based pharmacotherapy of panic disorder
Bakker, A., van Balkom, A. J. L. M., & Stein, D. J. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005201 · Cited by 44
Marks, I. M. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.3.200 · Cited by 44
State of the Science: The Hierarchical Taxonomy of Psychopathology (HiTOP)
Cicero, D. C., Ruggero, C. J., Balling, C. E., Bottera, A. R., Cheli, S., Elkrief, L., Forbush, K. T., Hopwood, C. J., Jonas, K. G., Jutras‐Aswad, D., et al. (2024) · Behavior Therapy · doi:10.1016/j.beth.2024.05.001 · Cited by 67
Wittkampf, K. A., Baas, K. D., van Weert, H. C. P. M., Lucassen, P. L., & Schene, A. H. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.10.030 · Cited by 43
“More importantly, response to treatment is good with a 70% recovery rate (Fava et al., 2001; Otto and Deveney, 2005; Furukawa et al., 2007).”
BackgroundEl Alaoui, S., Hedman, E., Ljótsson, B., Bergström, J., Andersson, E., Rück, C., Andersson, G., & Lindefors, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079024 · Cited by 39
“For example, we found no significant association between co-morbid disorders and treatment response, which stands in contrast to other studies where depression [14,25,28,29] and generalised anxiety disorder [24] was found to have an effect on treatment response.”
BackgroundResultEmmrich, A., Beesdo-Baum, K., Gloster, A. T., Knappe, S., Höfler, M., Arolt, V., Deckert, J., Gerlach, A. L., Hamm, A., Kircher, T., et al. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000335246 · Cited by 38
Park, J.-M., Mataix-Cols, D., Marks, I. M., Ngamthipwatthana, T., Marks, M., Araya, R., & Al-Kubaisy, T. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.6.543 · Cited by 37
Prognostic indices with brief and standard CBT for panic disorder: I. Predictors of outcome
DOW, M. G. T., KENARDY, J. A., JOHNSTON, D. W., NEWMAN, M. G., TAYLOR, C. B., & THOMSON, A. (2007) · Psychological Medicine · doi:10.1017/s0033291707000670 · Cited by 34
“1999; Ramnerö & Öst, 2004); co-morbid generalized anxiety disorder (Scheibe & Albus, 1997) ; concomitant depression (Keijsers et al. 1994; Ronalds et al. 1997; Sharp & Power, 1999; Fava et al. 2001) ; marital dissatisfaction (Dewey & Hunsley, 1990; Emmelkamp & Gerlsma, 1994); and personality disorder (Keijsers et al.”
BackgroundResultInfluentialBeyond extinction: Habituation eliminates conditioned skin conductance across contexts
Haesen, K., & Vervliet, B. (2014) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2014.11.010 · Cited by 41
“Both types of interventions are part of current treatment protocols for panic disorder (e.g., Barlow et al., 1989; Fava et al., 2001).”
BackgroundPanic disorder and agoraphobia: A direct comparison of their multivariate comorbidity patterns
Greene, A. L., & Eaton, N. R. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.060 · Cited by 41
“Indeed, the longest clinical trial of exposure therapy for PDþAG found that residual AG symptoms strongly predicted the recurrence of panic (Fava et al., 2001).”
BackgroundBitran, S., Morissette, S. B., Spiegel, D. A., & Barlow, D. H. (2008) · Behavior Modification · doi:10.1177/0145445507309019 · Cited by 41
“Although situational exposure-based treatments for PDA-MS are efficacious, many patients still do not improve, and if they do, many have residual agoraphobia and are at increased risk for relapse (Fava et al., 2001).”
BackgroundEye movements during recall of aversive memory decreases conditioned fear
Leer, A., Engelhard, I. M., Altink, A., & van den Hout, M. A. (2013) · Behaviour Research and Therapy · doi:10.1016/j.brat.2013.07.004 · Cited by 29
Healthcare Utilization Following Cognitive‐Behavioral Treatment for Panic Disorder with Agoraphobia
Roberge, P., Marchand, A., Reinharz, D., Cloutier, K., Mainguy, N., Miller, J., Bégin, J., & Turcotte, J. (2005) · Cognitive Behaviour Therapy · doi:10.1080/16506070510008443 · Cited by 44
“Although both treatments offer similar shortterm outcomes, CBT appears to offer superior maintenance of gains over time, whereas discontinuation of medication is associated with higher relapse rates (Fava et al., 2001; Gould, Otto, & Pollack, 1995;White & Barlow, 2002).”
BackgroundBiondi, M., & Picardi, A. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000067186 · Cited by 29
Predictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trial
Taylor, J. H., Jakubovski, E., & Bloch, M. H. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.03.020 · Cited by 25
“Prior studies have identified reduced CBT efficacy with concurrent benzodiazepine treatment (Fava et al., 2001), the development of tolerance, and prescription abuse as significant limitations to treating anxiety disorders with benzodiazepines (Michelini et al., 1996).”
BackgroundPanic Attacks and the Risk of Depression among Young Adults in the Community
Goodwin, R. D., Fergusson, D. M., & Horwood, L. J. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000076453 · Cited by 25
Oguz, G., Celikbas, Z., Batmaz, S., Cagli, S., & Sungur, M. Z. (2019) · International Journal of Cognitive Therapy · doi:10.1007/s41811-019-00047-5 · Cited by 23
Patients as Health Producers: The Psychosomatic Foundation of Lifestyle Medicine
Fava, G. A. (2023) · Psychotherapy and Psychosomatics · doi:10.1159/000529953 · Cited by 28
Self-citationThe functional impairment associated with personality disorders
Smith, T. L., & Benjamin, L. S. (2002) · Current Opinion in Psychiatry · doi:10.1097/00001504-200203000-00003 · Cited by 25
Implications of naturalistic use of pharmacotherapy in CBT treatment for panic disorder
Arch, J. J., & Craske, M. G. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2007.01.005 · Cited by 24
“(2) Presence of AG, which was dichotomized as none to mild AG (0) and or moderate to severe AG (1) and has demonstrated good reliability (DiNardo, Moras, Barlow, Rapee, & Brown, 1993).”
BackgroundInfluentialAuchter, A., Shumake, J., Gonzalez-Lima, F., & Monfils, M. (2017) · Scientific Reports · doi:10.1038/srep46071 · Cited by 23
Winter, D. A., Gournay, K., Metcalfe, C., & Rossotti, N. G. (2005) · Journal of Constructivist Psychology · doi:10.1080/10720530500311141 · Cited by 25
“…exposure treatment for agoraphobia are not atypical in that one classified 44 percent of the clients as treatment failures (Gournay, 1989), while the other reported that approximately one in three clients was unable to complete treatment or to benefit sufficiently from it (Fava et al., 2001).”
BackgroundWeck, F., Grikscheit, F., Höfling, V., Kordt, A., Hamm, A. O., Gerlach, A. L., Alpers, G. W., Arolt, V., Kircher, T. T. J., Pauli, P., et al. (2016) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2016.05.007 · Cited by 26
Are there advances in pharmacotherapy for panic disorder? A systematic review of the past five years
Caldirola, D., Alciati, A., Riva, A., & Perna, G. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1504921 · Cited by 22
Benecke, C., Huber, D., Staats, H., Zimmermann, J., Henkel, M., Deserno, H., Wiegand‐Grefe, S., & Schauenburg, H. (2016) · Zeitschrift für psychosomatische Medizin und Psychotherapie · doi:10.13109/zptm.2016.62.3.252 · Cited by 21
Podina, I. R., Vîslă, A., Fodor, L. A., & Flückiger, C. (2019) · Clinical Psychology Review · doi:10.1016/j.cpr.2019.101774 · Cited by 21
Dual-Tasking Attenuates the Return of Fear after Extinction
Leer, A., Engelhard, I. M., Dibbets, P., & van den Hout, M. (2013) · Journal of Experimental Psychopathology · doi:10.5127/jep.029412 · Cited by 22
Lancaster, C. L., Monfils, M., & Telch, M. J. (2020) · Behaviour Research and Therapy · doi:10.1016/j.brat.2020.103730 · Cited by 20
Countering Fear Renewal: Changes in the UCS Representation Generalize Across Contexts
Leer, A., & Engelhard, I. M. (2014) · Behavior Therapy · doi:10.1016/j.beth.2014.09.012 · Cited by 22
[Placental malaria and pregnancy outcome in a peri urban area in Senegal].
Ndao, C. T., Ndiaye, J. L., Gaye, A., & Hesran, J. L. (2006) · PubMed · Cited by 16
Comparing three extinction methods to reduce fear expression and generalization
Chen, Y., Lin, X., Ai, S., Sun, Y., Shi, L., Meng, S., Lü, L., & Shi, J. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113714 · Cited by 16
“Many studies proved that return of fear in the laboratory [62,63] and clinical practice [64, 65], indicating the fragility of extinction memories formed by standard extinction and NFE and CC were potential to promote new extinction learning.”
Verma, D., Tasan, R. O., Sperk, G., & Pape, H. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.01.011 · Cited by 17
“For instance, approximately 27% panic disorder patients have been reported with relapse following exposure-based therapies (Brown and Barlow, 1995; Fava et al., 2001).”
InfluentialThe psychological development of panic disorder: implications for neurobiology and treatment
Cosci, F. (2012) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462012000500003 · Cited by 19
Psychotherapy Plus Antidepressant for Panic Disorder With or Without Agoraphobia: Systematic Review
Furukawa, T. A., Watanabe, N., & Churchill, R. C. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.4.foc528 · Cited by 14
Residual symptoms in depression
Sonino, N., & Fava, G. A. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00200-2 · Cited by 23
Self-citationTreatment of panic disorder: recent developments and current status
Starčević, V. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.8.1219 · Cited by 15
Krause, K., Zhang, X. C., & Schneider, S. (2024) · Psychotherapy and Psychosomatics · doi:10.1159/000537932 · Cited by 17
“…our fi ndings with similar studies conducted with adult populations with a variety of mental disorders [45] or adult samples with speci fi c ADs [46, 47], effect sizes and remission rates are consistent or even exceed, which is remarkable, as the patient group with mixed ADs and comorbidity studied…”
ResultWendt, J., Hufenbach, M. C., König, J., & Hamm, A. O. (2020) · Scientific Reports · doi:10.1038/s41598-020-57934-7 · Cited by 15
Lorimer, B., Delgadillo, J., Kellett, S., & Lawrence, J. (2020) · Psychotherapy Research · doi:10.1080/10503307.2020.1733127 · Cited by 17
Exposure Therapy: Promoting Emotional Processing of Pathological Anxiety
Zalta, A. K., & Foa, E. B. (2012) · Wiley eBooks · doi:10.1002/9781118470886.ch4 · Cited by 20
Katzman, M. A., Bleau, P., Blier, P., Chokka, P. R., Kjernisted, K. D., & Ameringen, M. V. (2023) · doi:10.32920/14638581 · Cited by 13
Bullis, J. R., Eustis, E. H., Curreri, A. J., Cardona, N. D., Woods, B. K., Rosellini, A. J., Barlow, D. H., & Farchione, T. J. (2023) · Journal of Mood and Anxiety Disorders · doi:10.1016/j.xjmad.2023.100024 · Cited by 15
Zickgraf, H. F., & Schwartz, R. A. (2024) · Behaviour Research and Therapy · doi:10.1016/j.brat.2024.104677 · Cited by 13
Panic disorder and subthreshold panic in the light of comorbidity: a follow-up study
Oral, E., Aydın, N., Güleç, M., & Oral, M. (2012) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2012.01.009 · Cited by 13
“Especially in the presence of agoraphobia and comorbid conditions, PD causes significant impairment in life quality [17,18].”
BackgroundLeer, A., Haesen, K., & Vervliet, B. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00117 · Cited by 17
“004), and higher US expectancy during the fourth CS+ trial compared to the fourth CS− trial, t(58)= 20.”
Scholten, W., Batelaan, N. M., van Oppen, P., Smit, J. H., & van Balkom, A. J. L. M. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000350450 · Cited by 12
Treatment of Comorbid Anxiety Disorders and Depression
Fava, G. A., & Tomba, E. (2014) · The Wiley Handbook of Anxiety Disorders · doi:10.1002/9781118775349.ch53 · Cited by 10
Self-citationde Carvalho, M. R., Nardi, A. E., & Rangé, B. (2008) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832008000200004 · Cited by 9
Peter, H., Brückner, E., Hand, I., Rohr, W., & Rufer, M. (2007) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2006.05.004 · Cited by 16
Evidence-based pharmacotherapy of panic disorder
Batelaan, N. M., van Balkom, A. J. L. M., & Stein, D. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511910395.006 · Cited by 9
Effects of d -cycloserine on individual differences in relapse of fear
King, G., Graham, B. M., & Richardson, R. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.02.005 · Cited by 12
Sandell, R., Svensson, M., Nilsson, T., Johansson, H., Viborg, G., & Perrin, S. G. (2015) · Trials · doi:10.1186/s13063-015-0656-7 · Cited by 17
“Further favorable findings are available from an earlier uncontrolled study of PD patients treated with CBT wherein 82% of initial treatment responders remained in remission at 5 or more years post-treatment and 62% at 10 years or more [23]; however, the patients were less ill to begin with.”
BackgroundHoffart, A., Hedley, L. M., Svanøe, K., & Sexton, H. C. (2014) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.1934 · Cited by 11
Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia
Furukawa, T. A., Churchill, R. C., & Watanabe, N. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004364 · Cited by 8
Helbig‐Lang, S., Cammin, S., & Petermann, F. (2011) · Zeitschrift für Psychiatrie Psychologie und Psychotherapie · doi:10.1024/1661-4747/a000064 · Cited by 13
Effectiveness of cognitive-behavioral group therapy for panic disorder in a specialized unit.
Prats, E., Domínguez‐Clavé, E., Rosado, S., Pailhez, G., Bulbena, A., & Fullana, M. A. (2014) · Actas Españolas de Psiquiatría · Cited by 15
Metadata
- Authors
- FAVA, G. A., RAFANELLI, C., GRANDI, S., CONTI, S., RUINI, C., MANGELLI, L., & BELLUARDO, P.
- Affiliations
- University of Padua (IT)
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2001-07
- Volume
- 31
- Issue
- 5
- Pages
- 891-898
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2105906660
- Cited by
- 156
- References
- 15
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 8 · 2023: 5 · 2022: 1 · 2021: 9 · 2020: 9 · 2019: 7 · 2018: 11 · 2017: 2 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 9 · 2012: 13
- FWCI
- 11.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychological Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Assessments
- Keywords
- panic disorder with agoraphobia, exposure therapy, long-term outcomes, relapse, remission, agoraphobic avoidance, benzodiazepine use, antidepressant use, personality disorders, depressive mood, age
- MeSH terms
- Adult, Agoraphobia, Desensitization, Psychologic, Female, Follow-Up Studies, Humans, Male, Middle Aged, Recurrence, Comorbidity, Panic Disorder, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.